1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NSCLC Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market by Application
1.3.1 Global NSCLC Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Squamous Cell Lung Carcinoma
1.3.3 Large-cell Lung Carcinoma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NSCLC Drugs Market Perspective (2017-2028)
2.2 NSCLC Drugs Growth Trends by Region
2.2.1 NSCLC Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NSCLC Drugs Historic Market Size by Region (2017-2022)
2.2.3 NSCLC Drugs Forecasted Market Size by Region (2023-2028)
2.3 NSCLC Drugs Market Dynamics
2.3.1 NSCLC Drugs Industry Trends
2.3.2 NSCLC Drugs Market Drivers
2.3.3 NSCLC Drugs Market Challenges
2.3.4 NSCLC Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NSCLC Drugs Players by Revenue
3.1.1 Global Top NSCLC Drugs Players by Revenue (2017-2022)
3.1.2 Global NSCLC Drugs Revenue Market Share by Players (2017-2022)
3.2 Global NSCLC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NSCLC Drugs Revenue
3.4 Global NSCLC Drugs Market Concentration Ratio
3.4.1 Global NSCLC Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NSCLC Drugs Revenue in 2021
3.5 NSCLC Drugs Key Players Head office and Area Served
3.6 Key Players NSCLC Drugs Product Solution and Service
3.7 Date of Enter into NSCLC Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NSCLC Drugs Breakdown Data by Type
4.1 Global NSCLC Drugs Historic Market Size by Type (2017-2022)
4.2 Global NSCLC Drugs Forecasted Market Size by Type (2023-2028)
5 NSCLC Drugs Breakdown Data by Application
5.1 Global NSCLC Drugs Historic Market Size by Application (2017-2022)
5.2 Global NSCLC Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NSCLC Drugs Market Size (2017-2028)
6.2 North America NSCLC Drugs Market Size by Type
6.2.1 North America NSCLC Drugs Market Size by Type (2017-2022)
6.2.2 North America NSCLC Drugs Market Size by Type (2023-2028)
6.2.3 North America NSCLC Drugs Market Share by Type (2017-2028)
6.3 North America NSCLC Drugs Market Size by Application
6.3.1 North America NSCLC Drugs Market Size by Application (2017-2022)
6.3.2 North America NSCLC Drugs Market Size by Application (2023-2028)
6.3.3 North America NSCLC Drugs Market Share by Application (2017-2028)
6.4 North America NSCLC Drugs Market Size by Country
6.4.1 North America NSCLC Drugs Market Size by Country (2017-2022)
6.4.2 North America NSCLC Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe NSCLC Drugs Market Size (2017-2028)
7.2 Europe NSCLC Drugs Market Size by Type
7.2.1 Europe NSCLC Drugs Market Size by Type (2017-2022)
7.2.2 Europe NSCLC Drugs Market Size by Type (2023-2028)
7.2.3 Europe NSCLC Drugs Market Share by Type (2017-2028)
7.3 Europe NSCLC Drugs Market Size by Application
7.3.1 Europe NSCLC Drugs Market Size by Application (2017-2022)
7.3.2 Europe NSCLC Drugs Market Size by Application (2023-2028)
7.3.3 Europe NSCLC Drugs Market Share by Application (2017-2028)
7.4 Europe NSCLC Drugs Market Size by Country
7.4.1 Europe NSCLC Drugs Market Size by Country (2017-2022)
7.4.2 Europe NSCLC Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NSCLC Drugs Market Size (2017-2028)
8.2 Asia-Pacific NSCLC Drugs Market Size by Type
8.2.1 Asia-Pacific NSCLC Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific NSCLC Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific NSCLC Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific NSCLC Drugs Market Size by Application
8.3.1 Asia-Pacific NSCLC Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific NSCLC Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific NSCLC Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific NSCLC Drugs Market Size by Region
8.4.1 Asia-Pacific NSCLC Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific NSCLC Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NSCLC Drugs Market Size (2017-2028)
9.2 Latin America NSCLC Drugs Market Size by Type
9.2.1 Latin America NSCLC Drugs Market Size by Type (2017-2022)
9.2.2 Latin America NSCLC Drugs Market Size by Type (2023-2028)
9.2.3 Latin America NSCLC Drugs Market Share by Type (2017-2028)
9.3 Latin America NSCLC Drugs Market Size by Application
9.3.1 Latin America NSCLC Drugs Market Size by Application (2017-2022)
9.3.2 Latin America NSCLC Drugs Market Size by Application (2023-2028)
9.3.3 Latin America NSCLC Drugs Market Share by Application (2017-2028)
9.4 Latin America NSCLC Drugs Market Size by Country
9.4.1 Latin America NSCLC Drugs Market Size by Country (2017-2022)
9.4.2 Latin America NSCLC Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NSCLC Drugs Market Size (2017-2028)
10.2 Middle East & Africa NSCLC Drugs Market Size by Type
10.2.1 Middle East & Africa NSCLC Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa NSCLC Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa NSCLC Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa NSCLC Drugs Market Size by Application
10.3.1 Middle East & Africa NSCLC Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa NSCLC Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa NSCLC Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa NSCLC Drugs Market Size by Country
10.4.1 Middle East & Africa NSCLC Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa NSCLC Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck NSCLC Drugs Introduction
11.1.4 Merck Revenue in NSCLC Drugs Business (2017-2022)
11.1.5 Merck Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb NSCLC Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2017-2022)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Regeneron Pharmaceuticals
11.3.1 Regeneron Pharmaceuticals Company Details
11.3.2 Regeneron Pharmaceuticals Business Overview
11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Introduction
11.3.4 Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2017-2022)
11.3.5 Regeneron Pharmaceuticals Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis NSCLC Drugs Introduction
11.4.4 Novartis Revenue in NSCLC Drugs Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Jiangsu Hengrui Medicine
11.5.1 Jiangsu Hengrui Medicine Company Details
11.5.2 Jiangsu Hengrui Medicine Business Overview
11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Introduction
11.5.4 Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2017-2022)
11.5.5 Jiangsu Hengrui Medicine Recent Developments
11.6 Innovent Biologics
11.6.1 Innovent Biologics Company Details
11.6.2 Innovent Biologics Business Overview
11.6.3 Innovent Biologics NSCLC Drugs Introduction
11.6.4 Innovent Biologics Revenue in NSCLC Drugs Business (2017-2022)
11.6.5 Innovent Biologics Recent Developments
11.7 Shanghai Junshi Biosciences
11.7.1 Shanghai Junshi Biosciences Company Details
11.7.2 Shanghai Junshi Biosciences Business Overview
11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Introduction
11.7.4 Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2017-2022)
11.7.5 Shanghai Junshi Biosciences Recent Developments
11.8 BeiGene
11.8.1 BeiGene Company Details
11.8.2 BeiGene Business Overview
11.8.3 BeiGene NSCLC Drugs Introduction
11.8.4 BeiGene Revenue in NSCLC Drugs Business (2017-2022)
11.8.5 BeiGene Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NSCLC Drugs Introduction
11.9.4 Roche Revenue in NSCLC Drugs Business (2017-2022)
11.9.5 Roche Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca NSCLC Drugs Introduction
11.10.4 AstraZeneca Revenue in NSCLC Drugs Business (2017-2022)
11.10.5 AstraZeneca Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer NSCLC Drugs Introduction
11.11.4 Pfizer Revenue in NSCLC Drugs Business (2017-2022)
11.11.5 Pfizer Recent Developments
11.12 Boehringer-Ingelheim
11.12.1 Boehringer-Ingelheim Company Details
11.12.2 Boehringer-Ingelheim Business Overview
11.12.3 Boehringer-Ingelheim NSCLC Drugs Introduction
11.12.4 Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2017-2022)
11.12.5 Boehringer-Ingelheim Recent Developments
11.13 Teva
11.13.1 Teva Company Details
11.13.2 Teva Business Overview
11.13.3 Teva NSCLC Drugs Introduction
11.13.4 Teva Revenue in NSCLC Drugs Business (2017-2022)
11.13.5 Teva Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
